Ivi Madrid S.L.
- Address
- lock Available on a paid plan
Reproductive Medicine and Female Infertility
At Ivi Madrid S.L., clinical research in Medicina Reproductiva focuses on female infertility and assisted reproductive technologies, especially for women undergoing IVF and ICSI. These studies are designed to assess new ways to improve ovarian response and support better fertility treatment outcomes.
- Evaluating approaches to improve egg retrieval and ovarian function in women with reduced ovarian reserve
- Studying fertility treatments for women receiving ART, including those with an indication for IVF or ICSI
- Assessing whether new reproductive therapies can enhance the effectiveness of controlled ovarian stimulation
The site’s work in reproductive and urinary physiological phenomena supports research aimed at improving treatment effectiveness and expanding options for patients facing infertility.
Pregnancy-Related Conditions and Uterine Contractility
Research at this hospital/clinic also covers female urogenital diseases and pregnancy complications, with a particular interest in how reproductive treatments affect the uterus and early pregnancy environment. The goal is to better understand biological responses that may influence fertility care and pregnancy outcomes.
- Investigating medicines that may influence uterine contractility during fertility treatment
- Exploring how reproductive therapies interact with the body’s natural processes in women undergoing ART
- Supporting studies that aim to improve the safety and effectiveness of fertility-related care
This line of research helps clarify how treatment choices may affect reproductive physiology, with possible benefits for patients receiving advanced fertility care.
Innovative Support for Ovarian Stimulation
Another important area at Ivi Madrid S.L. is the evaluation of therapies used during controlled ovarian stimulation in women with infertility. These studies look at whether adding new supportive treatments can improve the number of oocytes obtained and strengthen outcomes in assisted reproduction.
- Testing new supportive therapies intended to improve ovarian response
- Measuring the impact of treatment combinations on egg production during IVF preparation
- Examining whether timing of treatment may affect reproductive results
The research reflects a broader effort to refine fertility treatment strategies and provide more effective options for women undergoing reproductive medicine care.
Reproductive Physiology and Treatment Effectiveness
Clinical trials at this site also examine how reproductive therapies work within the body, with attention to physiological phenomena involved in conception and fertility treatment. This includes research intended to improve understanding of treatment effects and support better decision-making in fertility medicine.
- Studying whether investigational fertility treatments can improve outcomes for women with infertility
- Assessing biological responses linked to IVF and ICSI care
- Generating evidence to help optimize reproductive treatment pathways
Overall, the research portfolio combines clinical evaluation and reproductive science to advance care for patients seeking help with conception.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Ivi Alicante S.L.1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Ferring Pharmaceuticals A/S2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Ivi Madrid S.L.
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Effects of Nolasiban Dosing Regimens on Uterine Contractility and Endocrine Parameters in Women Undergoing IVF/ICSI | ReproNovo ApS | Phase II | Recruiting | Jun 2026 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Follitropin Alfa | 1 | Unknown | — | — |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.